These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

724 related items for PubMed ID: 29143102

  • 1. Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears.
    Ren C, Zhu Y, Yang L, Zhang X, Liu L, Ren C.
    Arch Gynecol Obstet; 2018 Feb; 297(2):425-432. PubMed ID: 29143102
    [Abstract] [Full Text] [Related]

  • 2. A prospective study of women with ASCUS or LSIL pap smears at baseline and HPV E6/E7 mRNA positive: a 3-year follow-up.
    Bruno MT, Ferrara M, Fava V, Barrasso G, Panella MM.
    Epidemiol Infect; 2018 Apr; 146(5):612-618. PubMed ID: 29465024
    [Abstract] [Full Text] [Related]

  • 3. [Clinical effect evaluation of high risk human papilloma virus E6/E7 mRNA in triaging women with atypical squamous cells of undetermined significance].
    Guo Z, Zhao DM, Zhang SK, Wu ZN, Sun XB, Jia MM, Chen Q, Guo LW, Chen PP, Zhang JG.
    Zhonghua Zhong Liu Za Zhi; 2021 Oct 23; 43(10):1094-1099. PubMed ID: 34695901
    [Abstract] [Full Text] [Related]

  • 4. The clinical application of HPV E6/E7 mRNA testing in triaging women with atypical squamous cells of undetermined significance or low-grade squamous intra-epithelial lesion Pap smear: A meta-analysis.
    Yang L, Zhu Y, Bai Y, Zhang X, Ren C.
    J Cancer Res Ther; 2017 Oct 23; 13(4):613-620. PubMed ID: 28901302
    [Abstract] [Full Text] [Related]

  • 5. Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA.
    Perez Castro S, Iñarrea Fernández A, Lamas González MJ, Sarán Diez MT, Cid Lama A, Alvarez Martín MJ, Pato Mosquera M, López-Miragaya I, Estévez N, Torres Piñón J, Oña Navarro M.
    J Med Virol; 2013 Jun 23; 85(6):1063-8. PubMed ID: 23588733
    [Abstract] [Full Text] [Related]

  • 6. Intracellular human papillomavirus E6, E7 mRNA quantification predicts CIN 2+ in cervical biopsies better than Papanicolaou screening for women regardless of age.
    Pierry D, Weiss G, Lack B, Chen V, Fusco J.
    Arch Pathol Lab Med; 2012 Aug 23; 136(8):956-60. PubMed ID: 22849745
    [Abstract] [Full Text] [Related]

  • 7. The role of mRNA E6/E7 HPV high oncogenic risk expression in colposcopy of cervical intraepithelial neoplasia (CIN).
    Galarowicz B, Jach R, Kidzierska J, Dyduch G, Zajac K, Pityński K, Banaś T, Huras H, Streb J, Dulińska-Litewka J, Hosiawa V, Juszczak M, Milewicz T.
    Przegl Lek; 2012 Aug 23; 69(9):651-7. PubMed ID: 23401983
    [Abstract] [Full Text] [Related]

  • 8. The clinical value of HPV E6/E7 and STAT3 mRNA detection in cervical cancer screening.
    Fan Y, Shen Z.
    Pathol Res Pract; 2018 May 23; 214(5):767-775. PubMed ID: 29655523
    [Abstract] [Full Text] [Related]

  • 9. [Comparative study of HR HPV E6/E7 mRNA and HR-HPV DNA in cervical cancer screening].
    Zhao X, Cui Y, Jiang S, Meng Y, Liu A, Wei L, Liu T, Han H, Liu X, Liu F, Li Y.
    Zhonghua Yi Xue Za Zhi; 2014 Nov 25; 94(43):3432-5. PubMed ID: 25622677
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
    Han L, Husaiyin S, Zhao F, Rezhake R, Niyazi M.
    Clin Lab; 2018 Sep 01; 64(9):1363-1371. PubMed ID: 30274003
    [Abstract] [Full Text] [Related]

  • 14. Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.
    Yao YL, Tian QF, Cheng B, Cheng YF, Ye J, Lu WG.
    J Zhejiang Univ Sci B; 2018 Sep 01; 18(3):256-262. PubMed ID: 28271661
    [Abstract] [Full Text] [Related]

  • 15. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
    Kaufman RH, Adam E, Icenogle J, Reeves WC.
    Am J Obstet Gynecol; 1997 Oct 01; 177(4):930-6. PubMed ID: 9369847
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
    Liu TY, Xie R, Luo L, Reilly KH, He C, Lin YZ, Chen G, Zheng XW, Zhang LL, Wang HB.
    J Virol Methods; 2014 Feb 01; 196():120-5. PubMed ID: 24216236
    [Abstract] [Full Text] [Related]

  • 17. Human papillomavirus typing and viral gene expression analysis for the triage of women with abnormal results from papanicolaou test smears to colposcopy.
    Antonishyn NA, Horsman GB, Kelln RA, Severini A.
    Arch Pathol Lab Med; 2009 Oct 01; 133(10):1577-86. PubMed ID: 19792047
    [Abstract] [Full Text] [Related]

  • 18. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG, Wright TC, Litaker MS, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R.
    J Fam Pract; 1998 Feb 01; 46(2):125-34. PubMed ID: 9487318
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA.
    JAMA; 2002 Oct 09; 288(14):1749-57. PubMed ID: 12365959
    [Abstract] [Full Text] [Related]

  • 20. Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS.
    Zhu Y, Ren C, Yang L, Zhang X, Liu L, Wang Z.
    BMC Cancer; 2019 Mar 27; 19(1):271. PubMed ID: 30917784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.